Catalyst Wire Dossier Catalyst Wire Dossier

Influenza Vaccine, Trivalent Subunit Inactivated

influenza vaccine, trivalent subunit inactivated · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Influenza Vaccine, Trivalent Subunit Inactivated, covering 2014-10-01 to 2014-10-01. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above [Phase 4]

See pricing